Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q02556

Entry ID Method Resolution Chain Position Source
AF-Q02556-F1 Predicted AlphaFoldDB

365 variants for Q02556

Variant ID(s) Position Change Description Diseaes Association Provenance
CA8216726
RCV001297959
rs759579543
9 R>W Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA397000142
RCV001036891
rs764958679
15 I>M Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA397000176
rs1597249015
RCV001345765
20 S>G Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV001212056
rs1904878101
24 P>A Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
rs1904879589
RCV001206359
34 S>N Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
RCV000818680
CA397000486
rs1597251890
62 V>I Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA144516
COSM3728115
VAR_070084
rs397514711
RCV000050230
80 T>A Variant assessed as Somatic; impact. Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency haematopoietic_and_lymphoid_tissue IMD32A; impairs transcriptional activity by disrupting the interaction between IRF8 and DNA [NCI-TCGA, ClinVar, Cosmic, UniProt] Yes ClinGen
cosmic curated
ClinVar
UniProt
Ensembl
NCI-TCGA
dbSNP
RCV001036021
rs1905075639
80 T>R Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
COSM1581063
rs145048966
RCV000908730
CA8216795
96 T>M Immunodeficiency 32B haematopoietic_and_lymphoid_tissue [ClinVar, Cosmic] Yes ClinGen
cosmic curated
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA285717245
COSM559444
rs34712374
RCV001212474
97 D>N lung Variant assessed as Somatic; impact. Immunodeficiency 32B [Cosmic, NCI-TCGA, ClinVar] Yes ClinGen
cosmic curated
ClinVar
Ensembl
NCI-TCGA
dbSNP
RCV000050229
VAR_070085
CA144514
rs397514710
108 K>E Immunodeficiency 32B IMD32B; in resting macrophages, no effect on cytoplasmic subcellular localization; loss of nuclear subcellular localization upon IFN-gamma induction; decreased protein abundance; increased proteasome-dependent degradation; increased ubiquitination and sumoylation; loss of transcriptional repressor activity; loss of IRF1-dependent transcriptional repressor activity; loss of IRF1-dependent transcriptional activator activity; impairs transcriptional activity by disrupting the interaction between IRF8 and DNA [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs371942842
COSM1380274
RCV001239991
CA8216805
111 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine Immunodeficiency 32B [NCI-TCGA, Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
CA8216841
rs138854374
RCV000652536
124 V>M Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1905145046
RCV001346656
133 V>A Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
RCV000652524
CA397001035
rs1555509293
136 M>V Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs8052064
RCV000652523
CA8216851
138 C>W Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA8216852
RCV000899478
rs138032891
139 G>S Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000810837
CA8216856
RCV000482148
rs372863612
140 R>H Variant assessed as Somatic; 0.0 impact. Immunodeficiency 32B [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV001221642
rs755978434
CA8216862
145 E>K Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1212356919
RCV001048840
162 S>R Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
rs1363457499
RCV001341669
CA397001225
162 S>T Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs769456462
RCV000799897
CA8216898
170 R>G Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001296035
rs1905198107
183 S>G Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
RCV001224391
CA8216949
rs140514602
190 T>M Variant assessed as Somatic; 0.0 impact. Immunodeficiency 32B [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
NCI-TCGA
TOPMed
dbSNP
gnomAD
rs768395792
CA8216957
RCV001046301
197 A>V Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1905239908
RCV001221483
199 H>missing Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
RCV001193620
CA8217014
RCV000656479
rs144424711
RCV000557109
RCV001200602
201 A>V Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1427371180
CA397001536
RCV001038711
207 I>M Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs774835569
RCV001242309
CA8217026
RCV000656480
224 P>L Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA8217030
rs760910506
RCV001228047
225 E>K Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs148746145
RCV001706702
CA285734031
RCV000685109
228 R>C Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ESP
TOPMed
dbSNP
gnomAD
RCV001060820
rs1461824464
CA397001752
238 G>D Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
rs142267779
RCV000652534
RCV001528410
CA8217040
242 Y>H Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA8217046
rs773747033
RCV001233154
251 R>C Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
rs1242802767
RCV001299668
CA397001829
251 R>H Variant assessed as Somatic; 0.0 impact. Immunodeficiency 32B [NCI-TCGA, ClinVar] Yes ClinGen
ClinVar
NCI-TCGA
TOPMed
dbSNP
gnomAD
RCV002554845
RCV001092202
CA8217060
rs774034337
267 T>M Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA397002030
RCV001053683
rs1310418248
283 S>T Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
CA8217077
RCV000652525
rs28368114
287 V>M Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA8217106
rs202046728
RCV000585057
RCV001088823
328 F>V Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA8217140
rs369499000
RCV001224778
335 Y>C Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV000652526
rs36085113
CA8217146
344 G>S Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs771773479
CA8217157
RCV000688939
361 R>C Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV001297326
rs1905497880
361 R>H Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
RCV000824387
rs1597257806
CA397002574
365 I>V Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs774733201
RCV001065348
CA8217206
375 R>W Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
rs754985499
RCV001233722
CA8217213
387 A>S Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
dbSNP
gnomAD
RCV000652527
rs1555510153
390 V>missing Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
RCV001345307
rs1905549108
394 P>missing Immunodeficiency 32B [ClinVar] Yes ClinVar
dbSNP
RCV000702511
CA397002778
rs1567479042
395 E>A Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs756665891
RCV000797558
CA8217219
397 P>T Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA8217224
COSM253746
RCV001050530
rs748501841
404 R>W urinary_tract Immunodeficiency 32B [Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
ExAC
dbSNP
gnomAD
CA285737364
RCV001236028
rs901780905
415 R>I Immunodeficiency 32B [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
RCV000707337
rs1567479117
RCV001027585
CA891843544
RCV001766566
427 V>L Immunodeficiency 32B Inherited Immunodeficiency Diseases [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs886039596
RCV000255394
CA10588628
3 D>E No ClinGen
ClinVar
Ensembl
dbSNP
rs766524400
CA8216724
4 R>Q No ClinGen
ExAC
gnomAD
CA16620277
RCV000480436
rs1064796262
4 R>W No ClinGen
ClinVar
TOPMed
dbSNP
CA8216725
rs201464467
7 G>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA285711330
rs762945281
8 R>P No ClinGen
TOPMed
gnomAD
rs762945281
CA397000098
8 R>Q No ClinGen
TOPMed
gnomAD
CA397000096
rs1293439667
8 R>W No ClinGen
gnomAD
rs1192543113
CA397000113
11 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA397000119
rs1388876338
12 Q>L No ClinGen
TOPMed
rs1597248993
CA397000124
13 W>G No ClinGen
Ensembl
TCGA novel 15 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1597248997
CA397000137
15 I>V No ClinGen
Ensembl
CA397000147
rs1452914312
16 E>G No ClinGen
gnomAD
CA397000143
rs1347366121
16 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA397000163
rs1173576430
18 I>T No ClinGen
gnomAD
CA397000170
rs1391251618
19 D>G No ClinGen
gnomAD
rs377070739
CA8216729
20 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1396151109
CA397000193
22 M>I No ClinGen
TOPMed
rs751261768
CA285711351
22 M>K No ClinGen
ExAC
TOPMed
gnomAD
rs751261768
CA8216731
22 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA8216732
rs370086181
23 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA285711367
rs914225825
27 I>T No ClinGen
TOPMed
gnomAD
CA8216739
rs772616220
30 N>K No ClinGen
ExAC
TOPMed
CA8216737
rs779381872
30 N>S No ClinGen
ExAC
gnomAD
CA8216736
rs779381872
30 N>T No ClinGen
ExAC
gnomAD
rs747326308
CA8216740
COSM974538
32 E>D endometrium [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
CA8216741
rs770905943
33 K>R No ClinGen
ExAC
gnomAD
CA8216742
rs200775854
34 S>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA397000282
rs1215205167
35 M>I No ClinGen
gnomAD
rs140921131
CA8216743
35 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs763570356
CA285711428
35 M>V No ClinGen
gnomAD
rs1250694242
CA397000294
37 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 51 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA397000409
rs1167377783
53 D>H No ClinGen
gnomAD
rs1329459790
CA397000417
54 A>S No ClinGen
TOPMed
CA8216745
rs775453097
56 I>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 58 K>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1364266041
CA397000444
58 K>E No ClinGen
TOPMed
rs1474894975
CA397000466
59 A>S No ClinGen
gnomAD
rs758991256
CA8216773
61 A>G No ClinGen
ExAC
CA8216774
rs777937264
62 V>A No ClinGen
ExAC
TCGA novel 65 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1338775218
CA397000510
65 G>V No ClinGen
TOPMed
rs781442460
CA8216778
66 K>N No ClinGen
ExAC
rs757607650
CA8216777
66 K>Q No ClinGen
ExAC
CA8216779
rs746153058
67 F>L No ClinGen
ExAC
CA8216781
rs780120102
70 G>W No ClinGen
ExAC
gnomAD
rs749156548
CA8216782
71 D>E No ClinGen
ExAC
gnomAD
rs1402618760
CA397000547
71 D>N No ClinGen
gnomAD
rs768669423
CA8216783
72 K>N No ClinGen
ExAC
rs761647639
CA8216785
73 A>S No ClinGen
ExAC
gnomAD
CA397000562
rs761647639
73 A>T No ClinGen
ExAC
gnomAD
rs771805067
CA8216786
73 A>V No ClinGen
ExAC
CA8216790
rs79518337
74 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs760464695
CA8216789
74 E>K No ClinGen
ExAC
gnomAD
rs760464695
CA8216788
74 E>Q No ClinGen
ExAC
gnomAD
rs922368153
CA397000585
77 T>A No ClinGen
TOPMed
gnomAD
rs922368153
CA285717213
77 T>S No ClinGen
TOPMed
gnomAD
VAR_036490 81 R>K a breast cancer sample; somatic mutation [UniProt] No UniProt
CA397000622
rs1333675827
82 L>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs763333317
CA8216791
83 R>H No ClinGen
ExAC
gnomAD
rs764636779
CA8216792
85 A>V No ClinGen
ExAC
gnomAD
rs1348996824
CA397000652
87 N>D No ClinGen
gnomAD
CA397000681
rs1597251983
91 D>H No ClinGen
Ensembl
CA397000699
rs1597251986
93 E>A No ClinGen
Ensembl
TCGA novel 94 E>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1597251992
CA397000725
97 D>A No ClinGen
Ensembl
rs756331900
CA8216797
98 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA8216799
rs573204404
101 L>V No ClinGen
1000Genomes
ExAC
gnomAD
rs1395494815
CA397000762
103 I>F No ClinGen
gnomAD
CA8216802
rs748103332
107 Y>N No ClinGen
ExAC
gnomAD
CA397000801
rs1177789656
COSM974539
109 V>I Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA397000815
rs1430311441
111 R>G No ClinGen
gnomAD
rs371942842
CA8216804
111 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs941328654
CA285717354
113 V>L No ClinGen
TOPMed
CA8216807
rs770743217
117 E>D No ClinGen
ExAC
gnomAD
rs759051735
CA8216808
120 C>R No ClinGen
ExAC
gnomAD
rs145943537
CA8216839
121 K>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA397000953
rs1360555845
122 L>P No ClinGen
gnomAD
rs1399904643
CA397000959
123 G>A No ClinGen
gnomAD
CA397000961
rs138854374
124 V>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8216842
rs757116654
126 T>A No ClinGen
ExAC
gnomAD
rs1435382258
CA397000975
126 T>S No ClinGen
gnomAD
rs769356293
CA8216845
130 V>M No ClinGen
ExAC
gnomAD
CA285719702
rs867018516
131 N>S No ClinGen
TOPMed
gnomAD
CA8216846
rs779577615
132 E>K No ClinGen
ExAC
gnomAD
rs748716740
CA8216847
133 V>I No ClinGen
ExAC
gnomAD
CA285719739
rs1046132786
134 T>I No ClinGen
TOPMed
CA8216848
rs376865839
136 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs773694139
CA285719761
CA397001048
137 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs752999095
CA8216855
140 R>C No ClinGen
ExAC
gnomAD
rs752999095
CA397001062
140 R>G No ClinGen
ExAC
gnomAD
rs1412937994
CA397001069
141 S>F No ClinGen
gnomAD
CA8216857
rs764339986
141 S>P No ClinGen
ExAC
gnomAD
CA397001077
rs1597253275
142 E>D No ClinGen
Ensembl
rs751479059
CA8216858
143 I>V No ClinGen
ExAC
gnomAD
CA8216860
rs780993490
144 D>N No ClinGen
ExAC
rs139493882
CA8216864
147 I>M No ClinGen
1000Genomes
ExAC
gnomAD
CA8216863
rs779551389
147 I>V No ClinGen
ExAC
gnomAD
rs778397229
CA8216866
148 K>N No ClinGen
ExAC
gnomAD
rs1453162618
CA397001139
150 P>R No ClinGen
gnomAD
CA397001145
rs1287628750
151 S>C No ClinGen
TOPMed
rs139986397
CA8216889
154 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8216890
rs776013035
154 D>V No ClinGen
ExAC
TOPMed
gnomAD
rs1399913060
CA397001177
156 M>L No ClinGen
gnomAD
CA397001198
rs1368461271
158 M>I No ClinGen
gnomAD
rs1363457499
CA397001224
162 S>N No ClinGen
gnomAD
rs769033917
CA8216893
165 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs149439061
CA8216896
166 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA397001260
rs1450189378
168 A>T No ClinGen
gnomAD
rs1198799284
CA397001270
169 C>S No ClinGen
gnomAD
rs200427807
CA8216900
170 R>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs769456462
CA8216899
170 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1422967478
CA397001299
COSM704509
174 L>F lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1462189724
CA397001304
175 P>S No ClinGen
gnomAD
CA397001311
rs1167301439
176 D>Y No ClinGen
gnomAD
TCGA novel 177 W>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA397001321
rs1392035627
177 W>S No ClinGen
TOPMed
gnomAD
rs899829306
CA285721236
179 A>V No ClinGen
TOPMed
gnomAD
CA8216903
rs752392237
180 Q>* No ClinGen
ExAC
gnomAD
CA285721266
rs1033015653
180 Q>H No ClinGen
TOPMed
rs757846633
CA8216904
180 Q>R No ClinGen
ExAC
gnomAD
rs777345403
CA8216905
181 Q>E No ClinGen
ExAC
gnomAD
CA397001351
rs750840460
181 Q>H No ClinGen
ExAC
gnomAD
rs892689261
CA285721294
182 P>L No ClinGen
gnomAD
rs767204633
CA8216943
186 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA397001396
rs755555074
187 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8216946
rs755555074
187 P>Q No ClinGen
ExAC
TOPMed
gnomAD
CA8216945
rs755555074
187 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs140514602
CA8216950
190 T>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8216954
rs376705932
193 T>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs775333449
CA8216955
193 T>I No ClinGen
ExAC
gnomAD
rs775333449
CA397001428
193 T>N No ClinGen
ExAC
gnomAD
rs879093533
CA285722905
195 Y>H No ClinGen
Ensembl
rs1464758366
CA397001445
196 D>N No ClinGen
gnomAD
CA397001451
COSM33551
VAR_036491
rs1372132995
197 A>T breast a breast cancer sample; somatic mutation [Cosmic, UniProt] No ClinGen
cosmic curated
UniProt
TOPMed
dbSNP
gnomAD
CA8216958
rs774048246
198 H>Y No ClinGen
ExAC
gnomAD
rs1228334774
CA397001467
199 H>R No ClinGen
gnomAD
CA397001464
rs1330604246
199 H>Y No ClinGen
gnomAD
rs1253140691
CA397001478
201 A>T No ClinGen
gnomAD
rs778971066
CA8217016
202 F>V No ClinGen
ExAC
gnomAD
rs758259189
CA8217018
206 V>A No ClinGen
ExAC
gnomAD
rs752736280
CA8217017
206 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA397001544
rs1567477099
208 S>R No ClinGen
Ensembl
CA285733981
rs774613883
213 G>A No ClinGen
Ensembl
CA397001602
rs1467360615
216 V>M No ClinGen
gnomAD
rs780940426
CA8217022
218 Q>H No ClinGen
ExAC
rs1441582089
CA397001630
219 A>D No ClinGen
gnomAD
CA397001636
rs1597256641
220 T>P No ClinGen
Ensembl
CA397001649
rs1365396068
221 T>I No ClinGen
gnomAD
CA397001648
rs1365396068
221 T>S No ClinGen
gnomAD
CA285734003
rs867075236
222 T>N No ClinGen
Ensembl
rs1597256650
CA397001653
222 T>P No ClinGen
Ensembl
CA8217025
rs769407228
224 P>T No ClinGen
ExAC
TOPMed
gnomAD
rs1366430755
CA397001697
228 R>H No ClinGen
gnomAD
CA8217031
rs766477043
232 S>N No ClinGen
ExAC
gnomAD
rs759520672
CA397001728
CA397001729
233 Q>H No ClinGen
ExAC
TOPMed
gnomAD
rs776961095
CA397001727
233 Q>L No ClinGen
ExAC
gnomAD
CA8217032
rs776961095
233 Q>R No ClinGen
ExAC
gnomAD
CA8217034
rs765476821
235 G>V No ClinGen
ExAC
gnomAD
rs752611388
CA8217035
236 L>P No ClinGen
ExAC
gnomAD
rs763945332
CA8217038
238 G>C No ClinGen
ExAC
TOPMed
gnomAD
CA397001751
rs763945332
238 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA8217037
rs763945332
COSM339952
238 G>S lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA8217039
rs375458441
239 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs375458441
CA397001758
239 T>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8217042
rs755554608
244 P>L No ClinGen
ExAC
gnomAD
rs745602508
CA8217041
244 P>S No ClinGen
ExAC
gnomAD
rs1277105692
CA397001790
245 E>K No ClinGen
TOPMed
gnomAD
rs1277105692
CA397001791
245 E>Q No ClinGen
TOPMed
gnomAD
rs1335070725
CA397001798
246 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA397001803
rs1261942201
246 G>V No ClinGen
TOPMed
rs1597256733
CA397001818
249 L>R No ClinGen
Ensembl
CA8217045
rs772597014
249 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs771384589
CA8217048
254 P>L No ClinGen
ExAC
gnomAD
rs775730870
CA8217052
256 D>H No ClinGen
ExAC
TOPMed
gnomAD
rs775730870
CA8217053
256 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8217056
rs757001229
257 A>G No ClinGen
ExAC
gnomAD
rs751576714
CA8217055
257 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1361903859
CA397001868
258 I>V No ClinGen
gnomAD
CA397001887
rs376692640
260 S>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM303880
CA397001888
rs1297028658
261 E>K Variant assessed as Somatic; 0.0 impact. haematopoietic_and_lymphoid_tissue [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA397001897
rs1355753577
262 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 263 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1449730697
CA397001904
263 Q>R No ClinGen
gnomAD
TCGA novel 264 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749986122
CA8217058
266 V>G No ClinGen
ExAC
gnomAD
rs755787508
CA8217059
267 T>A No ClinGen
ExAC
gnomAD
CA8217063
COSM974542
rs778129733
268 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs754529909
CA8217062
268 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs1235535717
CA397001960
272 G>E No ClinGen
gnomAD
rs1905412024
RCV001172293
272 G>R No ClinVar
dbSNP
CA397001986
rs1158926419
276 R>C No ClinGen
gnomAD
CA8217067
rs746036448
276 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1310226478
CA397001991
277 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1597256807
CA397002000
278 V>G No ClinGen
Ensembl
rs1157572044
CA397001997
278 V>L No ClinGen
gnomAD
rs1157572044
CA397001995
278 V>M No ClinGen
gnomAD
rs775906478
CA8217069
279 L>M No ClinGen
ExAC
TOPMed
gnomAD
rs768927767
CA8217071
282 S>G No ClinGen
ExAC
gnomAD
rs370022572
CA8217072
284 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA397002033
rs767169156
284 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA8217074
rs767169156
284 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs370022572
CA8217073
284 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA397002050
rs28368114
287 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA397002058
rs1442047225
288 F>S No ClinGen
gnomAD
CA8217079
rs202107230
COSM3402529
289 V>I central_nervous_system [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA397002062
rs202107230
289 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA397002071
rs1363516045
290 K>R No ClinGen
TOPMed
CA8217081
rs751949620
292 L>R No ClinGen
ExAC
rs1177883312
CA397002102
295 G>S No ClinGen
gnomAD
rs1377715288
CA397002108
296 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA397002109
rs1408985036
296 R>H Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
TCGA novel 296 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1003823910
CA285734394
299 C>G No ClinGen
gnomAD
CA397002136
rs1332497689
300 S>N No ClinGen
gnomAD
CA285734415
rs945535357
301 G>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA8217086
rs780424115
303 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA8217088
rs371253181
304 V>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8217089
rs774512853
308 G>D No ClinGen
ExAC
gnomAD
TCGA novel 310 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772016377
CA8217091
310 P>S No ClinGen
ExAC
gnomAD
CA8217093
rs760447497
311 N>K No ClinGen
ExAC
gnomAD
CA397002218
rs1434809477
313 L>M No ClinGen
TOPMed
gnomAD
CA8217095
rs753421098
315 R>L No ClinGen
ExAC
gnomAD
CA397002235
rs753421098
315 R>P No ClinGen
ExAC
gnomAD
rs1207621165
CA397002248
317 E>G No ClinGen
TOPMed
CA8217096
rs759196494
318 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs759196494
CA397002252
318 V>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 319 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8217097
rs764598769
320 Q>R No ClinGen
ExAC
gnomAD
CA8217098
rs752281339
321 V>F No ClinGen
ExAC
rs756483517
CA8217102
323 D>A No ClinGen
ExAC
gnomAD
rs575823888
CA8217101
323 D>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs749472608
CA8217104
324 T>P No ClinGen
ExAC
gnomAD
CA397002307
rs1330330947
326 Q>H No ClinGen
TOPMed
rs768955460
CA8217105
326 Q>R No ClinGen
ExAC
gnomAD
rs202046728
CA397002317
328 F>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA397002325
rs1316275686
329 R>* No ClinGen
gnomAD
CA397002326
rs1217850601
329 R>Q No ClinGen
TOPMed
gnomAD
CA397002348
rs1394142597
330 E>D No ClinGen
gnomAD
CA397002369
rs1325141025
333 Q>H No ClinGen
TOPMed
rs369499000
CA397002381
335 Y>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA8217139
rs761450784
335 Y>N No ClinGen
ExAC
gnomAD
rs997972028
CA285736115
338 Q>R No ClinGen
TOPMed
rs1352249207
CA397002411
339 G>V No ClinGen
gnomAD
rs765523642
CA397002413
340 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA8217144
rs375352812
340 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs765523642
CA8217143
COSM1563458
340 R>W Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA397002429
rs1474391549
343 D>N No ClinGen
TOPMed
rs747057908
CA8217147
345 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA8217148
rs757374960
346 V>G No ClinGen
ExAC
gnomAD
CA397002448
rs1208994122
346 V>M No ClinGen
TOPMed
rs1378564440
CA397002456
347 V>G No ClinGen
gnomAD
CA8217149
rs781106355
347 V>M No ClinGen
ExAC
gnomAD
TCGA novel 351 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs139170705
CA8217150
354 F>S No ClinGen
1000Genomes
ExAC
gnomAD
rs769576986
CA8217151
355 P>T No ClinGen
ExAC
gnomAD
rs1216626084
CA397002515
356 D>N No ClinGen
TOPMed
CA397002525
rs1270074184
357 M>T No ClinGen
TOPMed
CA397002530
rs1448910180
358 A>T No ClinGen
gnomAD
CA397002535
rs1306912959
358 A>V No ClinGen
gnomAD
rs768392843
CA8217154
359 P>A No ClinGen
ExAC
gnomAD
CA397002541
rs1262372917
360 L>M No ClinGen
Ensembl
CA397002549
rs771773479
361 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA397002563
rs1370725029
363 K>R No ClinGen
TOPMed
CA397002580
rs765588362
366 L>I No ClinGen
ExAC
TOPMed
gnomAD
rs765588362
CA8217160
366 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA397002585
rs1200900321
367 V>M No ClinGen
gnomAD
CA8217163
rs764276050
368 Q>K No ClinGen
ExAC
gnomAD
rs751834077
CA8217164
368 Q>R No ClinGen
ExAC
gnomAD
rs1292712320
CA397002617
370 E>Q No ClinGen
TOPMed
gnomAD
CA397002636
rs1221891034
372 L>R No ClinGen
gnomAD
rs770530127
CA8217202
373 Y>C No ClinGen
ExAC
gnomAD
rs749812274
CA8217204
374 V>A No ClinGen
ExAC
gnomAD
TCGA novel 374 V>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs372592381
CA8217207
375 R>Q Variant assessed as Somatic; 9.292e-05 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs773542186
CA8217209
379 E>G No ClinGen
ExAC
gnomAD
rs760669482
CA397002687
381 A>S No ClinGen
ExAC
gnomAD
CA8217210
rs760669482
381 A>T No ClinGen
ExAC
gnomAD
CA285737244
rs956232894
384 S>N No ClinGen
TOPMed
CA397002710
rs1449299927
384 S>R No ClinGen
gnomAD
CA8217214
rs568111419
387 A>G No ClinGen
1000Genomes
ExAC
gnomAD
CA397002726
rs754985499
387 A>T No ClinGen
ExAC
gnomAD
rs758262133
CA8217216
388 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA397002734
rs1203457296
388 G>V No ClinGen
gnomAD
CA397002767
rs1283912318
393 A>D No ClinGen
gnomAD
CA8217218
rs746741171
395 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1025926878
CA285737286
397 P>L No ClinGen
TOPMed
CA397002792
rs1025926878
397 P>Q No ClinGen
TOPMed
rs756665891
CA285737281
397 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs749756916
CA8217221
398 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA285737313
rs955254231
398 P>S No ClinGen
Ensembl
rs910181916
CA285737315
399 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA8217223
rs774892491
401 Q>H No ClinGen
ExAC
gnomAD
rs772557507
CA8217225
404 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1567479072
CA397002841
405 M>I No ClinGen
Ensembl
rs1336576908
CA397002835
405 M>L No ClinGen
gnomAD
TCGA novel 408 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA397002870
rs1487726143
409 I>T No ClinGen
TOPMed
rs1452569476
CA397002876
410 C>Y No ClinGen
TOPMed
gnomAD
CA397002883
rs1310710585
411 A>S No ClinGen
gnomAD
rs1379760258
CA397002886
411 A>V No ClinGen
gnomAD
CA397002895
rs1279012687
413 H>Y No ClinGen
gnomAD
rs1346006665
CA397002914
415 R>S No ClinGen
gnomAD
COSM1709484
rs1221114403
CA397002918
416 S>L skin [Cosmic] No ClinGen
cosmic curated
gnomAD
CA397002926
rs1300472950
417 F>S No ClinGen
TOPMed
TCGA novel 419 R>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 421 N>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA397002964
rs1218757776
422 Q>R No ClinGen
TOPMed
rs1199023357
CA397002988
425 T>I No ClinGen
gnomAD
TCGA novel 425 T>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

No associated diseases with Q02556

12 regional properties for Q02556

Type Name Position InterPro Accession
repeat Leucine-rich repeat 592 - 651 IPR001611-1
repeat Leucine-rich repeat 662 - 707 IPR001611-2
repeat Leucine-rich repeat 709 - 766 IPR001611-3
repeat Leucine-rich repeat, typical subtype 590 - 613 IPR003591-1
repeat Leucine-rich repeat, typical subtype 614 - 636 IPR003591-2
repeat Leucine-rich repeat, typical subtype 638 - 660 IPR003591-3
repeat Leucine-rich repeat, typical subtype 661 - 684 IPR003591-4
repeat Leucine-rich repeat, typical subtype 685 - 706 IPR003591-5
repeat Leucine-rich repeat, typical subtype 707 - 730 IPR003591-6
repeat Leucine-rich repeat, typical subtype 731 - 751 IPR003591-7
repeat Leucine-rich repeat, typical subtype 753 - 776 IPR003591-8
domain LRRC8, pannexin-like TM region 1 - 340 IPR021040

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • In resting macrophages, localizes in the cytoplasm
  • Translocated in the nucleus upon IFN-gamma induction
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

4 GO annotations of molecular function

Name Definition
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
DNA-binding transcription repressor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that represses or decreases the transcription of specific gene sets transcribed by RNA polymerase II.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
sequence-specific double-stranded DNA binding Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding.

19 GO annotations of biological process

Name Definition
autophagy The cellular catabolic process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation.
cellular response to interferon-gamma Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
cellular response to lipopolysaccharide Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
defense response to bacterium Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
defense response to protozoan Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism.
dendritic cell differentiation The process in which a precursor cell type acquires the specialized features of a dendritic cell. A dendritic cell is a leukocyte of dendritic lineage specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation.
follicular B cell differentiation The process in which a B cell in the spleen acquires the specialized features of a follicular B cell. Follicular B cells are major population of mature recirculating B cells in the spleen and are located in the B-cell follicle region.
germinal center B cell differentiation The process in which a B cell in the spleen acquires the specialized features of a germinal center B cell. Germinal center B cells are rapidly cycling B cells which have downregulated IgD expression and exhibit high levels of binding by peanut agglutinin (PNA).
immune response Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
immune system process Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats.
myeloid cell differentiation The process in which a relatively unspecialized myeloid precursor cell acquires the specialized features of any cell of the myeloid leukocyte, megakaryocyte, thrombocyte, or erythrocyte lineages.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
phagocytosis A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles.
plasmacytoid dendritic cell differentiation The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a plasmacytoid dendritic cell.
positive regulation of interferon-gamma production Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
positive regulation of interleukin-12 production Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
regulation of type I interferon production Any process that modulates the frequency, rate, or extent of interferon type I production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q90871 IRF8 Interferon regulatory factor 8 Gallus gallus (Chicken) PR
Q00978 IRF9 Interferon regulatory factor 9 Homo sapiens (Human) PR
Q13568 IRF5 Interferon regulatory factor 5 Homo sapiens (Human) EV
Q15306 IRF4 Interferon regulatory factor 4 Homo sapiens (Human) SS
Q14653 IRF3 Interferon regulatory factor 3 Homo sapiens (Human) EV
Q92985 IRF7 Interferon regulatory factor 7 Homo sapiens (Human) EV
P23611 Irf8 Interferon regulatory factor 8 Mus musculus (Mouse) PR
10 20 30 40 50 60
MCDRNGGRRL RQWLIEQIDS SMYPGLIWEN EEKSMFRIPW KHAGKQDYNQ EVDASIFKAW
70 80 90 100 110 120
AVFKGKFKEG DKAEPATWKT RLRCALNKSP DFEEVTDRSQ LDISEPYKVY RIVPEEEQKC
130 140 150 160 170 180
KLGVATAGCV NEVTEMECGR SEIDELIKEP SVDDYMGMIK RSPSPPEACR SQLLPDWWAQ
190 200 210 220 230 240
QPSTGVPLVT GYTTYDAHHS AFSQMVISFY YGGKLVGQAT TTCPEGCRLS LSQPGLPGTK
250 260 270 280 290 300
LYGPEGLELV RFPPADAIPS ERQRQVTRKL FGHLERGVLL HSSRQGVFVK RLCQGRVFCS
310 320 330 340 350 360
GNAVVCKGRP NKLERDEVVQ VFDTSQFFRE LQQFYNSQGR LPDGRVVLCF GEEFPDMAPL
370 380 390 400 410 420
RSKLILVQIE QLYVRQLAEE AGKSCGAGSV MQAPEEPPPD QVFRMFPDIC ASHQRSFFRE
NQQITV